Article: Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae before and after introduction of 7-valent pneumococcal conjugate vaccine, Hong Kong, 1995-2009

File Download Links for fulltext
(May Require Subscription)
Supplementary

  • Basic View
  • Metadata View
  • XML View
TitleSerotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae before and after introduction of 7-valent pneumococcal conjugate vaccine, Hong Kong, 1995-2009
AuthorsHo, PL1
Chiu, SS1
Ang, I1
Lau, YL1
KeywordsDrug resistance
Heptavalent pneumococcal conjugate vaccine
Serotype replacement
Streptococcus pneumoniae
Issue Date2011
PublisherElsevier Ltd. The Journal's web site is located at http://www.elsevier.com/locate/vaccine
CitationVaccine, 2011, v. 29 n. 17, p. 3270-3275 [How to Cite?]
DOI: http://dx.doi.org/10.1016/j.vaccine.2011.02.025
AbstractThis study analyzed 828 isolates causing invasive pneumococcal disease (IPD) before (1995-2001, n=265) and after (2007-2009, n=563) the introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in Hong Kong. In children <5 years, serotype 14 had declined (36-15.7%, P<0.01) while 19A had increased (0-12.9%, P<0.01) in the before and after periods, respectively. In children aged <5 years, the proportion of PCV7 serotypes declined from 89.5% to 65.7% (72.8% if included cross protection against 6A) with time but that of PCV13 serotypes remained stable (91.4-93.2%). In elderly ≥65 years, 9V and 23F decreased from 3.8% to 0.3% (P=0.01) and from 18.9% to 7.4% (P <0.01), respectively while 7F increased significantly from 0% to 4.1% (P=0.04) over the same periods. Among isolates from aged <5 years, dual penicillin/erythromycin resistance increased from 44.1% to 64.2% (P=0.01). The types that often had dual penicillin/erythromycin resistance were 6B, 14, 19F, 23F, 6A and 19A. The emergence of serotype 19A was associated with expansion of sequence type 320. © 2011 Elsevier Ltd.
ISSN0264-410X
2011 Impact Factor: 3.766
2011 SCImago Journal Rankings: 0.369
DOIhttp://dx.doi.org/10.1016/j.vaccine.2011.02.025
ReferencesReferences in Scopus
DC Field
Value
dc.contributor.authorHo, PL
dc.contributor.authorChiu, SS
dc.contributor.authorAng, I
dc.contributor.authorLau, YL
dc.date.accessioned2011-07-27T01:33:42Z
dc.date.available2011-07-27T01:33:42Z
dc.date.issued2011
dc.description.abstractThis study analyzed 828 isolates causing invasive pneumococcal disease (IPD) before (1995-2001, n=265) and after (2007-2009, n=563) the introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in Hong Kong. In children <5 years, serotype 14 had declined (36-15.7%, P<0.01) while 19A had increased (0-12.9%, P<0.01) in the before and after periods, respectively. In children aged <5 years, the proportion of PCV7 serotypes declined from 89.5% to 65.7% (72.8% if included cross protection against 6A) with time but that of PCV13 serotypes remained stable (91.4-93.2%). In elderly ≥65 years, 9V and 23F decreased from 3.8% to 0.3% (P=0.01) and from 18.9% to 7.4% (P <0.01), respectively while 7F increased significantly from 0% to 4.1% (P=0.04) over the same periods. Among isolates from aged <5 years, dual penicillin/erythromycin resistance increased from 44.1% to 64.2% (P=0.01). The types that often had dual penicillin/erythromycin resistance were 6B, 14, 19F, 23F, 6A and 19A. The emergence of serotype 19A was associated with expansion of sequence type 320. © 2011 Elsevier Ltd.
dc.description.natureLink_to_subscribed_fulltext
dc.identifier.citationVaccine, 2011, v. 29 n. 17, p. 3270-3275 [How to Cite?]
DOI: http://dx.doi.org/10.1016/j.vaccine.2011.02.025
dc.identifier.citeulike8888203
dc.identifier.doihttp://dx.doi.org/10.1016/j.vaccine.2011.02.025
dc.identifier.epage3275
dc.identifier.hkuros187585
dc.identifier.isiWOS:000290603100027
Funding AgencyGrant Number
Food and Health Bureau of the Hong Kong SAR Government
Funding Information:

This study is supported by research grants from the Research Fund for the Control of Infectious Diseases of the Food and Health Bureau of the Hong Kong SAR Government. Authors had no conflict of interest to declare.

dc.identifier.issn0264-410X
2011 Impact Factor: 3.766
2011 SCImago Journal Rankings: 0.369
dc.identifier.issue17
dc.identifier.openurl
dc.identifier.pmid21352937
dc.identifier.scopuseid_2-s2.0-79954603483
dc.identifier.spage3270
dc.identifier.urihttp://hdl.handle.net/10722/135336
dc.identifier.volume29
dc.languageeng
dc.publisherElsevier Ltd. The Journal's web site is located at http://www.elsevier.com/locate/vaccine
dc.publisher.placeUnited Kingdom
dc.relation.ispartofVaccine
dc.relation.referencesReferences in Scopus
dc.subject.meshAnti-Bacterial Agents - pharmacology
dc.subject.meshBacterial Typing Techniques
dc.subject.meshPneumococcal Infections - epidemiology - microbiology
dc.subject.meshPneumococcal Vaccines - administration and dosage - immunology
dc.subject.meshStreptococcus pneumoniae - classification - drug effects - immunology - isolation and purification
dc.subjectDrug resistance
dc.subjectHeptavalent pneumococcal conjugate vaccine
dc.subjectSerotype replacement
dc.subjectStreptococcus pneumoniae
dc.titleSerotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae before and after introduction of 7-valent pneumococcal conjugate vaccine, Hong Kong, 1995-2009
dc.typeArticle
Author Affiliations
  1. The University of Hong Kong